Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-07-16
2011-10-25
Kosack, Joseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S654000, C548S503000
Reexamination Certificate
active
08044090
ABSTRACT:
The present invention provides compounds of formula (I), which are antagonists of the 5-HT6receptor.
REFERENCES:
patent: 3597149 (1971-08-01), Masuda et al.
patent: 5070096 (1991-12-01), Mohrs et al.
patent: 5093340 (1992-03-01), Mohrs et al.
patent: 5202336 (1993-04-01), Mohrs et al.
patent: 6187805 (2001-02-01), McAllister et al.
patent: 6750348 (2004-06-01), Bridger et al.
patent: 7157488 (2007-01-01), Chen et al.
patent: 2007/0099909 (2007-05-01), Chen
patent: 105267 (1962-10-01), None
patent: 105995 (1962-12-01), None
patent: 2181559 (1973-07-01), None
patent: 2 085 006 (1982-04-01), None
patent: 63-93765 (1988-04-01), None
patent: WO 93/11761 (1993-06-01), None
patent: WO 95/06638 (1995-03-01), None
patent: WO 95/30655 (1995-11-01), None
patent: WO 99/16746 (1999-04-01), None
patent: WO 00/34242 (2000-06-01), None
patent: WO-0042045 (2000-07-01), None
ACS Chemcats 2000:1020106, Order No. STOCK1S-08349, CAS Registry No. 302795-49-9.
Bos et al., “5-HT6 receptor antagonists: lead optimization and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides,” Eur J. Med. Chem., vol. 36, pp. 165-178 (2001).
Bourson et al, “Determination of the Role of the 5-ht6 Receptor in the Rat Brain: A Study using Antisense Oligonucleotides,” J. of Pharm. and Experimental Therapeutics, vol. 274, No. 1, pp. 173-180 (1995).
Meneses, Alfredo, “Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation,” Behavioral Brain Research, vol. 118, pp. 107-110 (2001).
Rogers et al., “5-HT6 receptor antagonists enhance retention of a water maze task in the rat,” PsvchopharmacoloEy, vol. 158, pp. 114-119 (2001).
Glennon, et al. “Influence of Amine Substituents on 5-HT2A versus 5-HT2C—Binding of Phenylakllyl- and Indolylalkylamines” J. Med. Chem., 1994, 37, 1929-1935.
Glennon, et al., 5-HT6 Serotonin Receptor Binding of Indolealkylamines: A Preliminary Structure-Affinity Investigation. Med. Chem. Res., 1999, 9, 108-117.
Ide et al. “Pharmacologically Active Compounds from Alkoxy-B-phenylethylamines” Journal of the American Chemical Society 1937, 726-731.
Tsai et al. “N1-(Benzenesulfonyl)tryptamines as Novel 5-HT6 Antagonists” Bioorganic & Medicinal Chemistry Letters 2000, 2295-2299.
Bromidge et al. “Phenyl Benzenesulfonamides are Novel and Selective 5-HT6 Antagonists: Identification of . . . ” Bioorganic & Medicinal Chemistry Letters 2001, 55-58.
Isaac et al. “6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-Bicyclopiperidinyl-1-arylsulfonylindoles Derivatives as Novel, Potent, and Selective 5-HT6 Receptor Antagonists” Bioorganic & Medicinal Chemistry Letters 2000, 1719-1721.
Database Crossfire Beilstein Online! Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; (3-ethoxy-benzyl)-(3-ethoxy-phenethyl)-amine), Database accession No. 3365863: XP002209140, 1992.
Database Crossfire Beilstein Online! Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; (3-ethoxy-benzyl)-(4-ethoxy-phenethyl)-amine), IDE, BUCK: Database accession No. 3365864; XP002209139, 1992.
Database Crossfire Beilstein Online! Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; (3-ethoxy-benzyl)-(2-ethoxy-henethyl)-amine), IDE, BUCK: Database accession No. 3380345; XP002209141, 1992.
Barton, et al., “886. Phenol Oxidation and Biosynthesis. Part VI. The Biogenesis of Amaryllidaceae Alkaloids,” Barton, Kirby, Taylor and Thomas, pp. 4545-4558 (1963).
Vinogradova, et al., “Synthesis Based on b-Phenylethylamines. IV. Synthesis and Antiarrhythmic Activity of Substituted Phenylalkylamines and N-Benzyltetrahydroisoquinolines,” vol. 29, No. 3, pp. 259-414 (1993).
Vinogradova, et al., “Syntheses Based on b-Ethylamines. VIII. Synthesis of Substituted 2-Benzyltetrahydroisoquinolines and Their Influence on Bile Secretion,” vol. 30, No. 3, pp. 368-370 (1994).
Chen Zhaogen
Cohen Michael Philip
Fisher Matthew Joseph
Giethlen Bruno
Gillig James Ronald
Eli Lilly
Kalinchak Stephen G.
Kosack Joseph
Lim Kitae
LandOfFree
N-(2-arylethyl)benzylamines as antagonists of the 5-HT6... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2-arylethyl)benzylamines as antagonists of the 5-HT6..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-arylethyl)benzylamines as antagonists of the 5-HT6... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294551